- Report
- October 2024
- 197 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- November 2024
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 191 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- November 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- April 2025
Global
From €4459EUR$4,900USD£3,823GBP
- Report
- October 2024
- 198 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 183 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- March 2025
- 190 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 182 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 180 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- July 2024
- 120 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 181 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 276 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 413 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 150 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 193 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 146 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 456 Pages
Global
From €5324EUR$5,850USD£4,564GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more